Sodium Danshensu ameliorates cerebral ischemia/reperfusion injury by inhibiting CLIC4 / NLRP3 inflammasome‐mediated endothelial cell pyroptosis
BioFactors · 2024
DOI: 10.1002/biof.1991 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Xiaolu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Reperfusion Injury, Brain Ischemia, Lactates. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: 2022 Annual Graduate Students Innovation Fund, School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China, National Natural Science Foundation of China, Natural Science Foundation of Tianjin City.
Abstract (Originalsprache)
Endothelial pyroptosis promotes cerebral ischemia/reperfusion injury (CIRI). Sodium Danshensu (SDSS) has been shown to attenuate CIRI and have anti‐inflammatory properties in endothelial cells. However, the mechanism and effect of SDSS on alleviating endothelial pyroptosis after CIRI remains poorly understood. Thus, we aimed to investigate the efficacy and mechanism of SDSS in reducing endothelial pyroptosis. It has been shown that SDSS administration inhibited NLRP3 inflammasome‐mediated pyroptosis . As demonstrated by protein microarrays, molecular docking, CETSA and ITDRF CETSA , SDSS bound strongly to CLIC4. Furthermore, SDSS can decrease its expression and inhibit its translocation. Its effectiveness was lowered by CLIC4 overexpression but not by knockdown. Overall The beneficial effect of SDSS against CIRI in this study can be ascribed to blocking endothelial pyroptosis by binding to CLIC4 and then inhibiting chloride efflux‐dependent NLRP3 inflammasome activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- Oncology Department, Ganzhou People's Hospital, Ganzhou, People's Republic of China.
ORCID-Profile: Xiaolu Zhang
Förderung
- 2022 Annual Graduate Students Innovation Fund, School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- Tianjin Graduate Research Innovation Project
- TUTCM Graduate Research Innovation Project
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Zhang, X., Yang, Q., Zhang, R., Zhang, Y., Zeng, W., Yu, Q., Zeng, M., Gan, J., Li, H., Yang, L., Gao, Q., & Jiang, X. (2024). Sodium Danshensu ameliorates cerebral ischemia/reperfusion injury by inhibiting CLIC4 / NLRP3 inflammasome‐mediated endothelial cell pyroptosis. BioFactors. https://doi.org/10.1002/biof.1991
Vancouver
Zhang X, Yang Q, Zhang R, Zhang Y, Zeng W, Yu Q, et al. Sodium Danshensu ameliorates cerebral ischemia/reperfusion injury by inhibiting CLIC4 / NLRP3 inflammasome‐mediated endothelial cell pyroptosis. BioFactors. 2024. doi:10.1002/biof.1991
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaolu and Yang, Qiuyue and Zhang, Ruifeng and Zhang, Yilin and Zeng, Wenyun and Yu, Qun and Zeng, Miao and Gan, Jiali and Li, Huhu and Yang, Lin and Gao, Qing and Jiang, Xijuan},
title = {Sodium Danshensu ameliorates cerebral ischemia/reperfusion injury by inhibiting CLIC4 / NLRP3 inflammasome‐mediated endothelial cell pyroptosis},
journal = {BioFactors},
year = {2024},
doi = {10.1002/biof.1991}
}
EUVIMED